title: Report of 6 cases of large granular lymphocytic leukemia and plasma cell dyscrasia.
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Penn State Hershey Cancer Institute, Hershey, PA. Electronic address: chengjihua@yahoo.com.
authors.forename: Jihua
authors.initials: J
authors.lastname: Cheng
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Penn State Hershey Cancer Institute, Hershey, PA.
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Talamo
authors.affiliation: Department of Anatomic & Clinical Pathology and Hematopathology, Penn State Milton S. Hershey Medical Center, Hershey, PA.
authors.forename: Jozef
authors.initials: J
authors.lastname: Malysz
authors.affiliation: Department of Hematology, Service d' Hematologie, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France.
authors.forename: Marlene
authors.initials: M
authors.lastname: Ochmann
authors.affiliation: Department of Hematology, Service d' Hematologie, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Lamy
authors.affiliation: Division of Hematology and Oncology, Department of Medicine, Penn State Hershey Cancer Institute, Hershey, PA.
authors.forename: Thomas P
authors.initials: TP
authors.lastname: Loughran
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000209:etiology; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001897:Boronic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D000069286:Bortezomib; D015984:Causality; D017338:Cladribine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D054066:Leukemia, Large Granular Lymphocytic / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D009503:Neutropenia / Q000209:etiology; D010265:Paraproteinemias / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D036102:Peripheral Blood Stem Cell Transplantation; D011241:Prednisone / Q000008:administration & dosage; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011719:Pyrazines / Q000008:administration & dosage / Q000627:therapeutic use; D012042:Registries; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D017338:Cladribine; D013792:Thalidomide; D000069286:Bortezomib; D003520:Cyclophosphamide; D000077269:Lenalidomide; D008558:Melphalan; D011241:Prednisone; D008727:Methotrexate
keywords: B lymphocytes; Immunotherapy; Large granular lymphocytic leukemia; Multiple myeloma; T lymphocytes